Business Context and Reporting Period
Nvni Group Limited filed a Form 6-K for January 2024. On January 12, 2024, the company disclosed a Nasdaq deficiency notice related to the composition of its board audit committee.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
- Randy Millian resigned from the company’s board of directors and audit committee effective December 29, 2023.
- Following the resignation, the audit committee has two members rather than the three members required under Nasdaq Listing Rule 5605.
Guidance, Risks, and Contingencies
- Nasdaq’s notice is a deficiency notification, not an imminent delisting notice, and currently has no effect on the listing or trading of the company’s ordinary shares on the Nasdaq Capital Market.
- The company generally has until the earlier of its next annual shareholders’ meeting or December 30, 2024, to regain compliance.
- If the next annual shareholders’ meeting occurs before June 26, 2024, the company must demonstrate compliance by June 26, 2024.
- If compliance is not achieved by the applicable deadline, Nasdaq may issue a written delisting notification. The company would then have the right to appeal to a Nasdaq Hearings Panel.
- Management expects to regain compliance before the applicable cure-period deadline.
Key Facts to Verify
- Whether the company appoints a qualified third audit committee member within the applicable cure period.
- The date of the next annual shareholders’ meeting and the resulting compliance deadline.
- Whether Nasdaq confirms that the company has regained compliance or initiates delisting procedures.
- Any subsequent disclosures regarding board composition, audit committee independence, or Nasdaq appeals.